TY - JOUR
T1 - Telephone-based depression self-management in Hispanic adults with epilepsy
T2 - a pilot randomized controlled trial
AU - Spruill, Tanya M.
AU - Friedman, Daniel
AU - Diaz, Laura
AU - Butler, Mark J.
AU - Goldfeld, Keith S.
AU - O'kula, Susanna
AU - Montesdeoca, Jacqueline
AU - Payano, Leydi
AU - Shallcross, Amanda J.
AU - Kaur, Kiranjot
AU - Tau, Michael
AU - Vazquez, Blanca
AU - Jongeling, Amy
AU - Ogedegbe, Gbenga
AU - Devinsky, Orrin
N1 - Publisher Copyright:
© 2021 The Author(s). Published by Oxford University Press on behalf of the Society of Behavioral Medicine.
PY - 2021/7
Y1 - 2021/7
N2 - Depression is associated with adverse outcomes in epilepsy but is undertreated in this population. Project UPLIFT, a telephone-based depression self-management program, was developed for adults with epilepsy and has been shown to reduce depressive symptoms in English-speaking patients. There remains an unmet need for accessible mental health programs for Hispanic adults with epilepsy. The purpose of this study was to evaluate the feasibility, acceptability, and effects on depressive symptoms of a culturally adapted version of UPLIFT for the Hispanic community. Hispanic patients with elevated depressive symptoms (n = 72) were enrolled from epilepsy clinics in New York City and randomized to UPLIFT or usual care. UPLIFT was delivered in English or Spanish to small groups in eight weekly telephone sessions. Feasibility was assessed by recruitment, retention, and adherence rates and acceptability was assessed by self-reported satisfaction with the intervention. Depressive symptoms (PHQ-9 scores) were compared between study arms over 12 months. The mean age was 43.3±11.3, 71% of participants were female and 67% were primary Spanish speakers. Recruitment (76% consent rate) and retention rates (86-93%) were high. UPLIFT participants completed a median of six out of eight sessions and satisfaction ratings were high, but rates of long-term practice were low. Rates of clinically significant depressive symptoms (PHQ-9 ≥5) were lower in UPLIFT versus usual care throughout follow-up (63% vs. 72%, 8 weeks; 40% vs. 70%, 6 months; 47% vs. 70%, 12 months). Multivariable-adjusted regressions demonstrated statistically significant differences at 6 months (OR = 0.24, 95% CI, 0.06-0.93), which were slightly reduced at 12 months (OR = 0.30, 95% CI, 0.08-1.16). Results suggest that UPLIFT is feasible and acceptable among Hispanic adults with epilepsy and demonstrate promising effects on depressive symptoms. Larger trials in geographically diverse samples are warranted.
AB - Depression is associated with adverse outcomes in epilepsy but is undertreated in this population. Project UPLIFT, a telephone-based depression self-management program, was developed for adults with epilepsy and has been shown to reduce depressive symptoms in English-speaking patients. There remains an unmet need for accessible mental health programs for Hispanic adults with epilepsy. The purpose of this study was to evaluate the feasibility, acceptability, and effects on depressive symptoms of a culturally adapted version of UPLIFT for the Hispanic community. Hispanic patients with elevated depressive symptoms (n = 72) were enrolled from epilepsy clinics in New York City and randomized to UPLIFT or usual care. UPLIFT was delivered in English or Spanish to small groups in eight weekly telephone sessions. Feasibility was assessed by recruitment, retention, and adherence rates and acceptability was assessed by self-reported satisfaction with the intervention. Depressive symptoms (PHQ-9 scores) were compared between study arms over 12 months. The mean age was 43.3±11.3, 71% of participants were female and 67% were primary Spanish speakers. Recruitment (76% consent rate) and retention rates (86-93%) were high. UPLIFT participants completed a median of six out of eight sessions and satisfaction ratings were high, but rates of long-term practice were low. Rates of clinically significant depressive symptoms (PHQ-9 ≥5) were lower in UPLIFT versus usual care throughout follow-up (63% vs. 72%, 8 weeks; 40% vs. 70%, 6 months; 47% vs. 70%, 12 months). Multivariable-adjusted regressions demonstrated statistically significant differences at 6 months (OR = 0.24, 95% CI, 0.06-0.93), which were slightly reduced at 12 months (OR = 0.30, 95% CI, 0.08-1.16). Results suggest that UPLIFT is feasible and acceptable among Hispanic adults with epilepsy and demonstrate promising effects on depressive symptoms. Larger trials in geographically diverse samples are warranted.
KW - Depression
KW - Disparities
KW - Epilepsy
KW - Hispanic/Latinx
KW - Mindfulness
KW - Telehealth
UR - http://www.scopus.com/inward/record.url?scp=85112434087&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85112434087&partnerID=8YFLogxK
U2 - 10.1093/tbm/ibab045
DO - 10.1093/tbm/ibab045
M3 - Article
C2 - 33963873
AN - SCOPUS:85112434087
SN - 1869-6716
VL - 11
SP - 1451
EP - 1460
JO - Translational Behavioral Medicine
JF - Translational Behavioral Medicine
IS - 7
ER -